Molina Healthcare (MOH) Stock Forecast & Price Target

Molina Healthcare is well positioned for earnings recovery because its core Medicaid business is showing signs of a margin turn, with 3Q26 favorability across Medicaid and Marketplace and management raising FY26 rate outlook to 4.5% against 5.5% trend. The company’s 5.0+ million members, 85%+ Medicaid mix, and concentrated state footprint provide scale and operating leverage, while the Nebraska work-requirement rollout appears more benign than expected, potentially limiting attrition. Preliminary 2027 building blocks point to more than $9.50 in adjusted EPS, supported by roughly $45 billion of premium revenue, the Florida CMS contract, the MAPD exit, and upside if Medicaid MCR improves.

Molina Healthcare is burdened by heavy dependence on government reimbursement, with more than 85% of members in Medicaid and over half concentrated in California, New York, Texas, and Washington, making earnings highly exposed to state rate-setting and contract renewals. The investment case is weakened by the risk that Medicaid cost trend stays above the ~5% assumption while rate adequacy lags, especially as OBBBA-related funding pressure, work requirements, and more frequent redeterminations could intensify membership attrition and delay margin recovery. Even with embedded earnings and a path to $25 EPS in 2029, the company has already shown execution risk through the downward revision of embedded earnings and Florida CMS assumptions, while Marketplace losses and a 2025 Medicare MCR of 92.4% add further pressure.